Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene

Journal of Clinical Investigation

Volumn 97, Issue 1, 1996, Pages 232-237

  Eitzman, Daniel T ^a   McCoy, Ronald D ^a   Zheng, Xianxian ^b   Fay, William P ^a   Shen, Tingliang ^b   Ginsburg, David ^a,b   Simon, Richard H ^a,c  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

collagen; fibrin; fibrinolysis; interstitial lung disease; plasmin

Indexed keywords

BLEOMYCIN; COLLAGEN; FIBRIN; HYDROXYPROLINE; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; FIBRINOLYSIS; GENE EXPRESSION; LUNG FIBROSIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0030054203     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118396     Document Type: Article

References (43)

1. Bertozzi, P., B. Astedt, L. Zenzius, K. Lynch, F. LeMaire, W. Zapol, and H. J Chapman. 1990. Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome. N Engl. J. Med. 322:890-897
2. Idell, S., K. K. James, E. G. Levin, B. S. Schwartz, N. Manchanda, R. J. Maunder, T R. Martin, J. McLarty, and D. S. Fair. 1989. Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome. J Clin. Invest. 84:695-705.
3. Bachofen, A . and E. R. Weibel. 1977. Alterations of the gas exchange apparatus in adult respiratory insutficiency associated with septicemia Am. Rev. Respir Dis. 116:589-615
4. Burkhardt, A 1989. Alveolitis and collapse in the pathogenesis of pulmonary fibrosis. Am. Rev. Respir. Dis. 140:513-524.
5. Kuhn, C , J Boldt, T J King, E. Crouch, T Vartio, and J. A McDonald. 1989. An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis. Am Rev Respir. Dis. 140:1693-1703
6. Basset, F , V. J. Ferrans, P. Soler, T. Takemura, Y. Fukuda, and R. G Crystal. 1986. Intraluminal fibrosis in interstitial lung disorders. Am. J. Pathol. 122:443-461
7. Fukuda, Y., M Ishizaki, Y. Masuda, G. Kimura, O. Kawanami, and Y Masugi. 1987 The role of intraalveolar fibrosis in the process of pulmonary structural remodeling in patients with diffuse alveolar damage. Am. J. Pathol. 126:171-182
8. Peyrol, S , J. F. Cordier, and J. A. Grimaud 1990. Intra-alveolar fibrosis of idiopathic bronchiolitis obliterans-organizing pneumonia. Cell-matrix patterns. Am. J. Pathol 137:155-170.
9. Crouch, E. 1990. Pathobiology of pulmonary fibrosis. Am J. Physiol. 259:L159-L184
10. Chapman, H A., C. L. Allen, and O. L. Stone. 1986. Abnormalities in pathways of alveolar fibrin turnover among patients with interstitial lung disease. Am. Rev. Respir. Dis 133:437-443
11. Hasday, J. L., P. R. Bachwich, J. P Lynch, and R. G Sitrin. 1988. Procoagulant and plasminogen activator activities of bronchoalveolar fluid in patients with pulmonary sarcoidosis. Exp. Lung Res 14:261-278
12. Viscardi, R M., K. Brodenck, C. C Sun, L A. Yale, A Hessamfar, V. Taciak, K C Burke, K. B. Koenig, and S Idell 1992. Disordered pathways of fibrin turnover in lung lavage of premature infants with respiratory distress syndrome. Am. Rev. Respir Dis 146:492-499.
13. Idell, S., K. K. James, and J. J. Coalson. 1992. Fibrinolytic activity in bronchoalveolar lavage of baboons with diffuse alveolar damage: trends in two forms of lung injury Crit Care Med 20:1431-1440.
14. Idell, S , K. K. James, C. Gillies, D S. Fair, and R. S Thrall. 1989. Abnormalities of pathways of fibrin turnover in lung lavage of rats with oleic acid and bleomycin-induced lung injury support alveolar fibrin deposition. Am. J Pathol 135:387-399
15. Idell, S., J. Peters, K. James, D. S. Fair, and C C. Coalson 1989. Local abnormalities in coagulation and fibrinolytic pathways that promote alveolar fibrin deposition in the lungs of baboons with diffuse alveolar damage. J. Clin. Invest 84.181-193.
16. Loskutoff, D. J., M. Sawdey, and J. Mimuro. 1989. Type 1 plasminogen activator inhibitor Prog. Hemostasis Thromb. 9:87-115.
17. Fay, W. P., A. D. Shapiro, J. L Shih, R. R Schleef, and D. Ginsburg. 1992. Complete deficiency of plasminogen-activator inhibitor type 1 due to a frame-shift mutation. N. Engl. J Med 327:1729-1733.
18. Carmeliet, P., J. M Stassen, L. Schoonjans, B Ream, J. J. van den Oord, M De Mol, R C. Mulligan, and D. Collen. 1993. Plasminogen activator inhibitor-1 gene-deficient mice. II Effects on hemostasis, thrombosis, and thrombolysis. J. Clin. Invest. 92:2756-2760.
19. Hamsten, A , B Wiman, U de Faire, and M. Blomback 1985. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N. Engl J Med 313:1557-1563
20. Wiman, B , and A Hamsten. 1990. The fibrinolytic enzyme system and its role in the etiology of thromboembolic disease. Semin. Thromb. Hemostasis. 16:207-216.
21. Carmeliet, P., L. Kieckens, L. Schoonjans, B. Ream, A. van Nuffelen, G Prendergast, M. Cole, R. Bronson, D. Collen, and R. C. Mulligan. 1993. Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization. J. Clin. Invest. 92:2746-2755.
22. Miller, S. A , D. D. Dykes, and H F Polesky. 1988 A simple salting out procedure for extracting DNA for human nucleated cells. Nucleic Acids Res. 16 1215.
23. Schrier, D J., S H. Phan, and B. M. McGairy. 1983. The effects of the nude (nu/nu) mutation on bleomycin-induced pulmonary fibrosis A biochemical evaluation. Am Rev Respir Dis 127:614-617.
24. Woessner, J. F. 1961. The determination of hydroxyproline in tissue and protein samples containing small proportions of this amino acid Arch. Biochem Biophys. 93:440-447.
25. Kirchheimer, J. C., and H. G Remold. 1989. Endogenous receptor-bound urokinase mediates tissue invasion of human monocytes J Immunol 143.2634-2639.
26. Werb, Z., C. L. Mainardi, C. A. Vater, and E. D. Harris 1977. Endogenous activation of latent collagenase by synovial cells: evidence for a role for plasminogen activator N Engl. J Med. 296:1017-1021.
27. Liotta, L. A., R. H. Goldfarb, R Brundange, G P. Siegal, V Terranova, and S. Garbisa. 1981. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. Cancer Res. 41:4629-4636.
28. Mochan, E , and T. Keler. 1984 Plasmin degradation of cartilage proteoglycan. Biochim Biophys. Acta. 800:312-315.
29. Chapman, H A., and O J. Stone. 1984. Cooperation between plasmin and elastase in elastin degradation by intact murine macrophages. Biochem. J. 222 721-728.
30. Laiho, M., and J. Keski-Oja 1989. Growth factors in the regulation of pericellular proteolysis: a review. Cancer Res. 49:2533-2553.
31. Dang, C. V., W. R. Bell, D. Kaiser, and A. Wang. 1985. Disorganization of cultured vascular epithelial cell monolayers by fibrinogen fragment D. Science (Wash. DC). 227:1487-1490.
32. Senior, R. M., W. F. Skugen, G. L. Griffin, and G. D. Wilner. 1986. Effects of fibrinogen derivatives upon the inflammatory response. Studies with human fibrinopeptide B. J. Clin. Invest 77:1014-1019.
33. Gross, T. J., R. H. Simon, C. J. Kelly, and R. G. Sitrin. 1991 Rat alveolar epithelial cells concomitantly express plasminogen activator intubitor-1 and urokinase. Am. J. Physiol. 260:L286-L295.
34. Marshall, B., B. Brown, M Rothstein, N. Rao, J. Hoidal, and G. Rodgers. 1991. Alveolar epithelial cells express both plasminogen activator and tissue factor. Chest. 99(Suppl. 3):25S-27S.
35. Erickson, L. A., G. J. Fici, J. E. Lund, T. P. Boyle, H. G. Polites, and K. R. Marotti. 1990 Development of venous occlusions in mice transgenic for the plasminogen activator inhibitor-1 gene. Nature (Lond.). 346:74-76
36. Carmeliet, P., L. Schoonjans, L. Kieckens, B. Ream, J. Degen, R. Bronson, R. De Vos, J J. van den Oord, D. Collen, and R. C. Mulligan. 1994. Physiological consequences of loss of plasminogen activator gene function in mice Nature (Lond.). 368:419-424.
37. Adamson, I. Y., and D. H Bowden 1974. The pathogenesis of bleomycin-induced pulmonary fibrosis. Am. J. Pathol. 77:185-197.
38. Idell, S., K. K. Gonzales, C. K. MacArthur, C. Gillies, P N. Walsh, J. McLarty, and R S Thrall 1987. Bronchoalveolar lavage procoagulant activity in bleomycin-induced lung injury in marmosets. Characterization and relationship to fibrin deposition and fibrosis. Am. Rev. Respir Dis 136:124-133.
39. Hart, D A , P. Whidden, F. Green, J Henkin, and D. E Woods 1994. Partial reversal of established bleomycin-induced pulmonary fibrosis by rhurokinase in a rat model. Clin. Invest. Med. 17:69-76.
40. Thrall, R. S., S. H. Phan, J. R. McCormick, and P A. Ward. 1981. The development of bleomycin-induced pulmonary fibrosis in neutrophil-depleted and complement-depleted rats. Am. J Pathol 105.76-81
41. Phan, S. J., R. S. Thrall, and C. Williams. 1981. Bleomycin-induced pulmonary fibrosis. Effects of steroid on lung collagen metabolism Am. Rev. Respir Dis 124:428-434.
42. Shen, A. S., C. Haslett, D. C Feldsien, P. M. Henson, and R. M. Cherniack. 1988. The intensity of chronic lung inflammation and fibrosis after bleomycin is directly related to the seventy of acute injury. Am Rev Respir. Dis. 137:564-571.
43. Eitzman, D. T., W. P. Fay, D. A. Lawrence, A. Francis-Chmura, J D. Shore, S. T. Olson, and D Ginsburg 1995. Peptide-mediated inactivation of recombinant and platelet plasminogen activator inhibitor-1 in vitro. J. Clin Invest 95:2416-2420